Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1681114

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1681114

Global Pharmaceutical Cold Chain Packaging Market Size Study, by Material (Plastics, Metal, Paper), by Product (Small Boxes, Pallets, Large Sized Pallet Containers), by End-Use, and Regional Forecasts 2022-2032

PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

The Global Pharmaceutical Cold Chain Packaging Market was valued at approximately USD 15.18 billion in 2023 and is poised to expand at a remarkable CAGR of 14.8% from 2024 to 2032. The increasing demand for temperature-sensitive pharmaceuticals, including biologics, vaccines, and specialty drugs, has significantly intensified the need for robust and efficient cold chain packaging solutions. As pharmaceutical manufacturers focus on preserving product efficacy and compliance with stringent regulatory requirements, investment in innovative and sustainable packaging materials is accelerating. Moreover, technological advancements such as phase change materials (PCMs), vacuum-insulated panels (VIPs), and real-time monitoring systems are transforming the industry by ensuring product integrity throughout the supply chain.

The growing trend of precision medicine, coupled with the surging demand for biologics and biosimilars, is driving a paradigm shift in the pharmaceutical packaging landscape. Cold chain packaging plays a pivotal role in ensuring product stability from manufacturing to administration, preventing temperature excursions that could compromise drug potency. Furthermore, the expansion of e-commerce pharmaceutical sales and home-based healthcare services has amplified the necessity for advanced cold chain logistics and packaging solutions. Market players are heavily investing in eco-friendly packaging alternatives to minimize environmental impact while adhering to evolving sustainability regulations. The surge in personalized medicine and cell & gene therapies is further fueling the demand for customized cold chain solutions, creating lucrative growth opportunities.

Stringent global regulatory frameworks, including FDA, EMA, and WHO guidelines, have necessitated compliance-driven innovations in cold chain packaging solutions. The pharmaceutical industry's shift toward digital supply chain monitoring, leveraging IoT-enabled packaging and AI-driven logistics, is reshaping cold chain management strategies. Additionally, the emergence of modular packaging solutions designed for multi-use applications is gaining traction, enabling cost efficiencies while ensuring product safety. However, high initial costs and operational complexities associated with maintaining a seamless temperature-controlled supply chain may pose challenges to market expansion.

The North American market currently leads the global pharmaceutical cold chain packaging industry, driven by stringent healthcare regulations, the presence of leading biopharmaceutical firms, and expanding R&D investments in novel drug formulations. The United States remains a dominant player, with increasing adoption of smart packaging technologies that enhance real-time temperature tracking and reduce logistical risks. Europe, particularly Germany, France, and the UK, follows closely, leveraging strong regulatory compliance frameworks and technological advancements in insulated packaging solutions. Meanwhile, the Asia-Pacific region is poised for the fastest growth, fueled by expanding pharmaceutical production in China and India, rising government initiatives for vaccine distribution, and growing investments in cold chain infrastructure. Latin America and the Middle East & Africa markets are gradually emerging, driven by improving healthcare access and increasing demand for temperature-sensitive biologics and specialty drugs.

Major market players included in this report are:

  • Sonoco ThermoSafe
  • Pelican BioThermal LLC
  • Cold Chain Technologies, LLC
  • Cryopak
  • Sofrigam SA
  • Intelsius
  • AmerisourceBergen Corporation
  • Sealed Air Corporation
  • DGP Intelsius Ltd.
  • Peli BioThermal
  • Softbox Systems Ltd.
  • Snyder Industries, Inc.
  • Envirotainer AB
  • va-Q-tec AG
  • CSafe Global

The detailed segments and sub-segments of the market are explained below:

By Material

  • Plastics
  • Metal
  • Paper

By Product

  • Small Boxes
  • Pallets
  • Large-Sized Pallet Containers

By End-Use

  • Pharmaceutical Manufacturers
  • Biotechnology Companies
  • Specialty Drug Distributors
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Years considered for the study are as follows:

  • Historical Year: 2022
  • Base Year: 2023
  • Forecast Period: 2024-2032

Key Takeaways:

  • Market estimates & forecasts spanning 10 years (2022-2032).
  • Detailed revenue breakdowns with regional-level insights for all market segments.
  • Comprehensive geographical assessment, including country-level dynamics.
  • Competitive landscape analysis featuring key players and their strategic initiatives.
  • Evaluation of emerging trends and expert recommendations for market participants.
  • Examination of demand-supply factors influencing market growth.

Table of Contents

Chapter 1. Global Pharmaceutical Cold Chain Packaging Market Executive Summary

  • 1.1. Global Pharmaceutical Cold Chain Packaging Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Material
    • 1.3.2. By Product
    • 1.3.3. By End-Use
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Pharmaceutical Cold Chain Packaging Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory Frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Pharmaceutical Cold Chain Packaging Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Surging Demand for Temperature-Sensitive Pharmaceuticals
    • 3.1.2. Accelerated Investment in Innovative and Sustainable Packaging Materials
    • 3.1.3. Technological Advancements in Cold Chain Solutions
  • 3.2. Market Challenges
    • 3.2.1. High Initial Costs and Operational Complexities
    • 3.2.2. Compliance with Stringent Regulatory Requirements
  • 3.3. Market Opportunities
    • 3.3.1. Digital Supply Chain Monitoring and IoT-Enabled Packaging
    • 3.3.2. Eco-Friendly Packaging Innovations
    • 3.3.3. Expansion of Modular and Multi-Use Packaging Solutions

Chapter 4. Global Pharmaceutical Cold Chain Packaging Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top Investment Opportunity
  • 4.4. Top Winning Strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Pharmaceutical Cold Chain Packaging Market Size & Forecasts by Material 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Pharmaceutical Cold Chain Packaging Market: Material Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
    • 5.2.1. Plastics
    • 5.2.2. Metal
    • 5.2.3. Paper

Chapter 6. Global Pharmaceutical Cold Chain Packaging Market Size & Forecasts by Product 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Pharmaceutical Cold Chain Packaging Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
    • 6.2.1. Small Boxes
    • 6.2.2. Pallets
    • 6.2.3. Large-Sized Pallet Containers

Chapter 7. Global Pharmaceutical Cold Chain Packaging Market Size & Forecasts by Region 2022-2032

  • 7.1. North America Pharmaceutical Cold Chain Packaging Market
    • 7.1.1. U.S. Market
      • 7.1.1.1. Material Breakdown Size & Forecasts, 2022-2032
      • 7.1.1.2. Product Breakdown Size & Forecasts, 2022-2032
    • 7.1.2. Canada Market
  • 7.2. Europe Pharmaceutical Cold Chain Packaging Market
    • 7.2.1. UK Market
    • 7.2.2. Germany Market
    • 7.2.3. France Market
    • 7.2.4. Spain Market
    • 7.2.5. Italy Market
    • 7.2.6. Rest of Europe Market
  • 7.3. Asia-Pacific Pharmaceutical Cold Chain Packaging Market
    • 7.3.1. China Market
    • 7.3.2. India Market
    • 7.3.3. Japan Market
    • 7.3.4. Australia Market
    • 7.3.5. South Korea Market
    • 7.3.6. Rest of Asia-Pacific Market
  • 7.4. Latin America Pharmaceutical Cold Chain Packaging Market
    • 7.4.1. Brazil Market
    • 7.4.2. Mexico Market
    • 7.4.3. Rest of Latin America Market
  • 7.5. Middle East & Africa Pharmaceutical Cold Chain Packaging Market
    • 7.5.1. Saudi Arabia Market
    • 7.5.2. South Africa Market
    • 7.5.3. Rest of Middle East & Africa Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Sonoco ThermoSafe
    • 8.1.2. Pelican BioThermal LLC
    • 8.1.3. Cold Chain Technologies, LLC
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Sonoco ThermoSafe
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Market Strategies
    • 8.3.2. Pelican BioThermal LLC
    • 8.3.3. Cold Chain Technologies, LLC
    • 8.3.4. Cryopak
    • 8.3.5. Sofrigam SA
    • 8.3.6. Intelsius
    • 8.3.7. AmerisourceBergen Corporation
    • 8.3.8. Sealed Air Corporation
    • 8.3.9. DGP Intelsius Ltd.
    • 8.3.10. Peli BioThermal
    • 8.3.11. Softbox Systems Ltd.
    • 8.3.12. Snyder Industries, Inc.
    • 8.3.13. Envirotainer AB
    • 8.3.14. va-Q-tec AG
    • 8.3.15. CSafe Global

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!